Atlanta Braves EVP Schiller sells 175,395 shares

The sale was made under a Rule 10b5-1 plan adopted June 30, 2026, at a weighted average price of $53.20 per share.

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. EVP, Business Derek Gordon Schiller exercised options to acquire 175,395 Series C Common Stock shares at an exercise price of $27.18 per share on September 30, 2026, then sold 175,395 shares at a weighted average price of $53.20 per share. The sale prices ranged from $52.41 to $54.10 per share. The sale was made under a Rule 10b5-1 sales plan adopted June 30, 2026.

Insider Trade Summary 10b5-1

Exercise and Sale: 175,395 shares ($4.56M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Schiller Derek Gordon

Role EVP, Business

Sold 175,395 shs ($9.33M)

Approx. gross sale proceeds $9.33M

Approx. exercise cost $4.77M

Approx. pre-tax spread $4.56M

Type	Security	Shares	Price	Value
Exercise	Stock option (Right to Buy) - BATRK F1	175,395	$0.00	$0.00
Exercise	Series C Common Stock	175,395	$27.18	$4.77M
Sale	Series C Common Stock F1, F2	175,395	$53.20	$9.33M

Holdings After Transaction: Stock option (Right to Buy) - BATRK — 0 contracts (Direct); Series C Common Stock — 316,908 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 30, 2026.
2. F2. Reflects the weighted average sale price. The range of prices for such transaction is $52.41 to $54.10. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

Key Figures

Shares acquired on option exercise: 175,395 shares Option exercise price: $27.18 per share Shares sold: 175,395 shares +2 more

5 metrics

Shares acquired on option exercise 175,395 shares September 30, 2026

Option exercise price $27.18 per share September 30, 2026

Shares sold 175,395 shares September 30, 2026

Weighted average sale price $53.20 per share September 30, 2026

Sale price range $52.41 to $54.10 per share September 30, 2026

Key Terms

Rule 10b5-1 sales plan, weighted average sale price, exercise price

3 terms

Rule 10b5-1 sales plan regulatory

"pursuant to a Rule 10b5-1 sales plan"

weighted average sale price financial

"Reflects the weighted average sale price"

exercise price financial

"conversion_or_exercise_price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BATRA shares did Derek Gordon Schiller sell, and at what price?

Derek Gordon Schiller sold 175,395 Series C Common Stock shares on September 30, 2026, at a weighted average price of $53.20 per share. The sale prices ranged from $52.41 to $54.10 per share, and the sale was made under a Rule 10b5-1 plan adopted June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:05 PM Accepted by SEC EDGAR 10/01/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schiller Derek Gordon

(Last) (First) (Middle)

C/O ATLANTA BRAVES HOLDINGS, INC.

755 BATTERY AVENUE SE

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Business

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series C Common Stock	09/30/2026		M		175,395	A	$27.18	492,303	D
Series C Common Stock	09/30/2026		S(1)		175,395	D	$53.2(2)	316,908	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (Right to Buy) - BATRK	$27.18	09/30/2026		M(1)			175,395	12/10/2023	12/10/2027	Series C Common Stock	175,395	$0	0	D

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 30, 2026.

2. Reflects the weighted average sale price. The range of prices for such transaction is $52.41 to $54.10. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

	/s/ Greg Heller, Attorney-in-Fact	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)